These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

843 related items for PubMed ID: 9329559

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. II. Prediction of prognosis.
    Ståhle E, Glimelius B, Bergström R, Påhlman L.
    Eur J Surg Oncol; 1988 Aug; 14(4):287-96. PubMed ID: 3165870
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer].
    Kokhanenko NIu, Ignashov AM, Varga EV, Polkanova MS, Aleshina LA, Kimbarovskaia AA, Osipenko SK, Lebedev EG.
    Vopr Onkol; 2001 Aug; 47(3):294-7. PubMed ID: 11544826
    [Abstract] [Full Text] [Related]

  • 45. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M, Pilarsky E, Kersting S, Grützmann R.
    Int J Surg; 2013 Aug; 11(10):1067-72. PubMed ID: 24161419
    [Abstract] [Full Text] [Related]

  • 46. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Acta Obstet Gynecol Scand; 2008 Aug; 87(11):1136-42. PubMed ID: 18951217
    [Abstract] [Full Text] [Related]

  • 47. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer.
    Dilege E, Mihmanli M, Demir U, Ozer K, Bostanci O, Kaya C, Aksakal O, Sakiz D.
    Hepatogastroenterology; 2010 Aug; 57(99-100):674-7. PubMed ID: 20698248
    [Abstract] [Full Text] [Related]

  • 48. Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
    Spila A, Roselli M, Cosimelli M, Ferroni P, Cavaliere F, Arcuri R, Tedesco M, Carlini S, D'Alessandro R, Perri P, Casciani CU, Greiner JW, Schlom J, Guadagni F.
    Anticancer Res; 1996 Aug; 16(4B):2241-7. PubMed ID: 8694550
    [Abstract] [Full Text] [Related]

  • 49. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL, Diez M, Torres A, Maestro M, Ortega D, Hernando F, Gómez A, Garcia-Asenjo J, Balibrea JL.
    Cancer; 1996 Mar 15; 77(6):1066-72. PubMed ID: 8635125
    [Abstract] [Full Text] [Related]

  • 50. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
    Imada T, Rino Y, Takahashi M, Hatori S, Shiozawa M, Amano T, Kondo J.
    Hepatogastroenterology; 1999 Mar 15; 46(27):2086-90. PubMed ID: 10430402
    [Abstract] [Full Text] [Related]

  • 51. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 15; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 52. Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
    van Dalen A, Favier J, Baumgartner L, Hasholzner U, de Bruijn H, Dobbler D, Dombi VH, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Einarsson R.
    Anticancer Res; 1999 Jan 15; 19(4A):2523-6. PubMed ID: 10470187
    [Abstract] [Full Text] [Related]

  • 53. Phospholipids, tumour marker and beta-CrossLaps in diagnosis of gastric carcinoma.
    Oremek GM, Sapoutzis N, Lorenz M.
    Anticancer Res; 2003 Jan 15; 23(2A):859-63. PubMed ID: 12820314
    [Abstract] [Full Text] [Related]

  • 54. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS, Wu TL, Tsao KC, Sun CF.
    Ann Clin Lab Sci; 2006 Jan 15; 36(1):23-30. PubMed ID: 16501233
    [Abstract] [Full Text] [Related]

  • 55. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.
    Thorac Cardiovasc Surg; 2009 Oct 15; 57(7):403-8. PubMed ID: 19795327
    [Abstract] [Full Text] [Related]

  • 56. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.
    Ann Thorac Surg; 2007 Feb 15; 83(2):419-24. PubMed ID: 17257963
    [Abstract] [Full Text] [Related]

  • 57. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M, Itoh T.
    Eur J Cardiothorac Surg; 2004 Apr 15; 25(4):520-2. PubMed ID: 15037265
    [Abstract] [Full Text] [Related]

  • 58. The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA.
    Duraker N, Celik AN.
    J Surg Oncol; 2001 Apr 15; 76(4):266-71. PubMed ID: 11320518
    [Abstract] [Full Text] [Related]

  • 59. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
    Treska V, Topolcan O, Stanislav K, Liska V, Holubec L.
    Hepatogastroenterology; 2009 Apr 15; 56(90):317-20. PubMed ID: 19579590
    [Abstract] [Full Text] [Related]

  • 60. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K, Meyer F, Schmidt U, Lippert H.
    Zentralbl Chir; 2005 Aug 15; 130(4):353-61. PubMed ID: 16103961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.